Navigation Links
Cambrex Reports Second Quarter of 2011 Results
Date:8/2/2011

EAST RUTHERFORD, N.J., Aug. 2, 2011 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM) reports second quarter results for the period ended June 30, 2011.

Highlights

  • Reported sales increased by 17.6%, and excluding the impact of foreign currency, sales increased 6.9% compared to the second quarter of 2010.
  • EBITDA was $13.2 million in the second quarter of 2011, an increase of 8.6% compared to $12.1 million in the second quarter of 2010.
  • Debt, net of cash was $75.5 million at the end of the second quarter of 2011, an improvement of $7.1 million during the quarter which includes a positive $0.4 million currency impact on foreign cash balances.

  • Second Quarter of 2011 Operating Results – Continuing OperationsSales in the second quarter of 2011 of $67.5 million were 17.6% higher than the second quarter of 2010. Excluding a 10.7% favorable impact of foreign exchange, reflecting a weaker U.S. dollar, sales increased 6.9%.  The increase is primarily due to higher sales of certain larger custom manufacturing products and higher volumes of generic APIs.  These increases were partially offset by the timing of orders for certain products, lower custom development revenues and lower pricing across several product categories.  

    Second quarter of 2011 Gross Margin decreased to 28.2% from 31.2% during the second quarter of 2010, with foreign currency unfavorably impacting gross margin by 2.3% in the second quarter of 2011.  Gross margins were negatively impacted by lower pricing partially offset by higher sales and production volumes and lower production costs.  

    Selling, General and Administrative Expenses in the second quarter of 2011 were $9.2 million compared to $8.2 million in the same period last year.  The increase is primarily due to unfavorable foreign exchange.

    Research
    '/>"/>

    SOURCE Cambrex Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Cambrex Reports Third Quarter 2010 Results
    2. Cambrex Reports Fourth Quarter and Full Year 2009 Results
    3. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Nominated for 2009 Innovations Award
    4. Cambrex Reports First Quarter 2009 Results
    5. Cambrex Receives Notice Regarding NYSE Listing
    6. Cambrex Reports Third Quarter 2008 Results
    7. Jennerex Reports Positive Mechanistic Proof-of-Concept Clinical Trial Results Using JX-594 to Treat Metastatic Melanoma
    8. Gen-Probe Reports Financial Results for the Second Quarter of 2011
    9. Neurocrine Biosciences Reports Second Quarter 2011 Results
    10. United Therapeutics Corporation Reports Second Quarter 2011 Financial Results
    11. Sangamo BioSciences Reports Second Quarter 2011 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/10/2014)... CA (PRWEB) July 10, 2014 Senior ... institutions and professional associations, addressed the challenges of “Reducing ... Medical Device Industries” through strategic sourcing. Describing the partnership ... with the Supply Chain Management Institute ( SCMI) ... event on June 24 at the Kroc Institute of ...
    (Date:7/10/2014)... Utah , July 10, 2014 /PRNewswire-iReach/ ... annotation and interpretation, today announced an agreement ... (NGS) analytics for Lineagen,s NextStep Dx ... of neurodevelopmental and neurological disorders, currently offers ... microarray (CMA) testing service used by healthcare ...
    (Date:7/10/2014)... fight against terrorism with the creation of a sensor ... use of light and special glass fibres. , Published ... , the researchers describe a novel optical fibre sensor ... 6.3 ppm (parts per million). It requires an analysis ... detection has involved looking for metals that encase them ...
    (Date:7/10/2014)... quantum Hall effect in bilayer graphene and shown that ... an electric field. , The fractional quantum Hall ... sheets are exposed to large magnetic fields, is a ... electrons behave as a single system. However, while the ... details of this collective behavior remain not well understood, ...
    Breaking Biology Technology:Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 2Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 4Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 3Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 4Detecting trace amounts of explosives with light 2Columbia researchers observe tunable quantum behavior in bilayer graphene 2Columbia researchers observe tunable quantum behavior in bilayer graphene 3
    ... ATS Medical, Inc.,(Nasdaq: ATSI ), manufacturer and marketer ... received FDA clearance for the,marketing of the ATS 3f(R) Aortic ... improved valve holder accessory device. , ... While the ATS 3f Aortic Bioprosthesis ...
    ... Alert,Limited (OTC Bulletin Board: DYMC) is pleased to ... for its pharmaceutical product line-up. The,modalities will include ... onset,through oromucosal absorption, topical applications, such as lotions ... products will have,specific uses, while others may treat ...
    ... December 5 Elsevier, the,world,s leading publisher of scientific ... Young Indian Scientist Award. Prof. J J,Theo Groothuizen, S&T ... at Le Meridien in New Delhi. , ... to recognize outstanding young scientists and,researchers in India who ...
    Cached Biology Technology:ATS Medical Provides Update on US Commercialization of Its ATS 3f Aortic Bioprosthesis 2ATS Medical Provides Update on US Commercialization of Its ATS 3f Aortic Bioprosthesis 3Dynamic Outlines Initial Target Markets for Pharmaceutical Cannabinoid Products 2Dynamic Outlines Initial Target Markets for Pharmaceutical Cannabinoid Products 3Elsevier Announces Winners of 3rd Annual Scopus Young Indian Scientist Award 2Elsevier Announces Winners of 3rd Annual Scopus Young Indian Scientist Award 3
    (Date:7/11/2014)... kidney injury related to the use of hydroxyethyl starch ... molecules, according to a report in Anesthesia & ... Society (IARS). , The "total mass of HES molecules" ... renal proximal tubule cells (PTCs), concludes the laboratory study ... Wrzburg, Austria. Other factorssuch as differences in the ...
    (Date:7/11/2014)... 2014 Research and Markets has ... Market - Industry Analysis Size Share Growth Trends and ... http://photos.prnewswire.com/prnh/20130307/600769 The ... a need for high level security in both private ... such as username and passwords, tokens etc. are vulnerable ...
    (Date:7/10/2014)... YORK , June 27, 2014  Pomerantz ... Provectus Biopharmaceuticals, Inc. ("Provectus" or the "Company")(NYSE-MKT: PVCT) ... filed in United States District Court, Middle District ... is on behalf of a class consisting of ... acquired Provectus securities between December 17, 2013 and ...
    Breaking Biology News(10 mins):In lab studies, hydroxyethyl starch has direct harmful effects on kidney cells 2International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3
    ... - Imagine the marriage of hard metals or semiconductors to ... hybrid materials never conceived by Mother Nature. ... Steven Lenhert, the newest faculty face of nanoscience at The ... fitted with a "lab on a chip" that can diagnose ...
    ... study suggests that jewel scarab beetles find each otherand ... the 3D effects for the blockbuster movie Avatar. ... jewel scarab species Chrysina gloriosa can distinguish ... provide the beetles with a tremendous advantage, the researchers ...
    ... in Nunavut are as tall as their U.S. counterparts but they,re ... edition of the International Journal of Circumpolar Health . ... infants began life with equivalent birth lengths, but were falling behind ... is in many ways a good news story," says Dr. Tracey ...
    Cached Biology News:Bionanotechnology has new face, world-class future at Florida State 2Bionanotechnology has new face, world-class future at Florida State 3Beetles stand out using 'Avatar' tech 2Patterns of growth changing in Inuit preschoolers 2
    Alexa Fluor 647 anti-mouse Qa-2...
    ... The Luminex 100 Instrument System is ... assays using Upstate's Beadlyte reagents. The ... Dell computer with software version 1.7, ... Delivery System. Upstate offers $2000 in ...
    EDG-6 Lysate Source: Cell Lysate Application: Western Blotting Control Form: IgG...
    PC12 (rat phaeochromocytoma) cells Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
    Biology Products: